University of Utah
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).
University of Utah: 818 sponsored US clinical trials, 138 recruiting.
University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.
Top-decile sponsor footprint
University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
818 total, page 15 of 17
Pilot Study of Alternative Treatments of Unexplained Chronic Fatigue
NCT00983502
Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver
NCT00742911
Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study
NCT00722943
Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation)
NCT00748878
Does High Intraoperative Inspired Oxygen Reduce Postoperative Arterial Oxygen Saturation?
NCT00715741
The Effects of Celecoxib on Bone Ingrowth
NCT00585156
The Effect of Interscalene Peripheral Nerve Block With 0.25% Bupivacaine vs 0.125% Bupivacaine on Lung Function
NCT01429584
Effect of Adipokines in Hemodialysis Patients
NCT01301027
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
NCT01274143
Aquatic Treadmill Therapy for Improving Gait, Balance, Fitness and Quality of Life in Stroke Patients
NCT00983827
Bone Marrow Transplant Chart Review for RIC
NCT00723333
Reducing Falls With RENEW in Older Adults Who Have Fallen
NCT01080196
Non-Contrast Enhanced Peripheral Magnetic Resonance Angiography
NCT02823444
Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
NCT00669396
Patent Foramen Ovale in Children With Migraine Headaches
NCT00750594
CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I
NCT00661453
Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients
NCT00708448
Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea
NCT00708526
Pilot Study on Sleep Management for US Veterans
NCT00933959
Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
NCT00708721
A Novel Mutation of the Spectrin Gene
NCT00723567
Dialysis Registry in Utah
NCT02023528
Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants
NCT00833222
Comparison of Humidified High Flow Nasal Cannula to Nasal CPAP in Neonates
NCT00609882
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
NCT00706810
Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State
NCT00585468
Comparison of Conventional and Custom Photorefractive Keratectomy (PRK)
NCT00713856
A Study of Neurophysiologically Based Occupational Therapy Intervention (NBOTI) for Feeding in the NCCU.
NCT00766051
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
NCT00707343
Comparison of LASIK and SBK
NCT00714363
Comparison of Photorefractive Keratectomy (PRK) and Sub-Bowman's Keratomileusis (SBK)
NCT00714922
VA Integrated Medication Manager
NCT01787175
Methadone Pharmacokinetics and Cardiac Effects in Newborns
NCT00715988
DHA Supplementation in Patients With STGD3
NCT00420602
Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease
NCT00566670
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
NCT00694096
Cancer Symptom Monitoring Telephone System With Nurse Practitioner (NP) Follow up
NCT01973946
FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
NCT00707213
Strength Training and Medication Effects in Parkinson Disease Effects on Hypokinesia in Parkinson Disease
NCT00665184
Serum Metal Ion Concentrations Following Primary Hip Arthroplasty
NCT00714610
Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer
NCT00585377
Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
NCT00481013
Electronic Pharmacotherapy Risk Management
NCT00828490
Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy
NCT00528268
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients
NCT00585221
Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD
NCT00506285
A Multi-modality Imaging Assessment of Chemobrain
NCT00708045
High-Resolution Diffusion Tensor Imaging (DTI) of the Cervical Spinal Cord in the Setting of Spinal Cord Injury (SCI)
NCT01407705
Nasopharyngeal Pressure Measurement During Neonatal Nasal Respiratory Support
NCT00766194
Effects of Vitamin D on Renin Expression in Hypertensive Patients
NCT00585442
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 145 |
| Phase 2 | 123 |
| Phase 3 | 18 |
| Phase 4 | 27 |
Therapeutic Areas
What is open in the University of Utah pipeline
138 recruiting of 818 indexed (17% open); 492 completed (60%).
Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).
Top condition: Low Back Pain (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Utah: open-pipeline peers nationwide
Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 818 trials (± recruiting share)
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
Sponsors near 17% open enrollment (± trial volume)
- University of Hawaii · 17% recruiting · 77 trials
- Penn State University · 17% recruiting · 219 trials
- AdventHealth · 17% recruiting · 95 trials
- CSL Behring · 17% recruiting · 71 trials
Related
What to do with this University of Utah page
818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.
- 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Utah pipeline card: 818 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.